PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12655060::ACT031262

mAc-AMP2

Evidence text

Paper-level observation

Section 3.3: mAc-AMP2 inhibited adhesion of the clinical isolate 8.2 by 96% at concentration of 12.5 µM.
textConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antifungal
Measure
percent_inhibition
Comparator
=
Raw observation
96%
Normalized measurement
=96%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Candida albicans
Assay method
Not reported by source
Sequence
VGECVRGRCPSGACCSQWGYCGKGPKYCGR
Standardization
ready simple

Source publication

Modified Hevein-like Peptide from Amaranthus caudatus as a Promising Agent Against Pathogenic Candida Species

Pharmaceutics · 2025

DOI 10.3390/pharmaceutics17111406 PMC12655060
Parent mention

Related peptide identities

PEPDIA-PLP-002970

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.